期刊文献+

合同研究组织的发展及我国应采取的对策 被引量:10

The Developments of CRO and Strategies We Should Take
下载PDF
导出
摘要 随着全球医药产业的迅猛发展和新药研究开发难度的增加,合同研究组织(CRO)作为一个新兴的医药产业形式迅速发展起来。本文在系统阐述合同研究组织的定义、功能及其兴起背景的基础上,以美国、欧洲、亚洲为例,详细的介绍合同研究组织在世界范围内的发展状况及在未来几年内的发展趋势,并分析我国合同研究组织的发展现状、存在问题。同时,结合我国的国情,提出了发展我国合同研究组织应采取的对策。 With the rapidly developments of global pharmaceutical industry and much greater challenges pharmaceutical companies have to face during drug research and development, Contract Research Organization (CRO) as a new branch of pharmaceutical industry grows quickly all over the world. In this paper, first of all, we systemically introduce the definition and function of CRO, the reason why CRO grow so quickly in recent years. Then we choose America, Europe and Asia as examples to explain the development of CRO. In the end, we analyze the development of CRO in China, point out the problems exit in the developments ; at the same time we give several pieces of advice for the development of CRO in China.
作者 阿丽塔 田玲
出处 《医学信息学杂志》 CAS 2008年第5期29-33,共5页 Journal of Medical Informatics
关键词 合同研究组织 新药 研发 对策 CRO Novel drug Research and develop Strategy
  • 相关文献

参考文献15

  • 1吴宗颐.CRO中国医药行业的后起之秀[J].医药世界,2004(4):29-31. 被引量:5
  • 2[2]Ina Chapman.Evolving With Contemporary Contract Research[J].Nature Reviews,2003,2:597.
  • 3[3]Why Do Prescription Drugs Cost So Much?[OL]PhRMA.www.phrma.org/publications/publications/brochure/questions/.2005-5-23.
  • 4[4].DiMasi JA.The Price of Innovation:New Estimates of Drug Development Costs[J].Journal of Health Economics,2003,22:151-185.
  • 5[5]Gluck ME.Federal Policies Affecting the Cost and Availability of New Pharmaceuticals[J].The Kaiser Family Foundation.2002.
  • 6[6]Lundy J.Prescription Drug Trends:A Chart Book Update[OL].The Kaiser Family Foundation.http://www.kff.org,2005-5-23.
  • 7[7]Henry I.Miller and David R Henderson.Governmental Influences on Drug Development:Striking A Better Balance[J].Nature,2007,6:532-539.
  • 8桑国卫.国际医药产业发展特点与我国创新药物研究近况[J].齐鲁药事,2005,24(1):17-22. 被引量:14
  • 9[9]CDER Drug and Biologic Approval Reports.FDA/Center for Drug Evaluation and Research[OL].http://www.fda.gov/cder/rdmt/default.htm.2007-9-4.
  • 10谢琪,黄卫平,崔天红.浅谈合同研究组织对我国制药业的作用[J].中国中医药信息杂志,2004,11(5):377-378. 被引量:9

二级参考文献3

共引文献24

同被引文献65

引证文献10

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部